61 related articles for article (PubMed ID: 18297522)
1. Prognostic factors in patients with diffuse large B cell lymphoma: Before and after the introduction of rituximab.
Ngo L; Hee SW; Lim LC; Tao M; Quek R; Yap SP; Loong EL; Sng I; Hwan-Cheong TL; Ang MK; Ngeow J; Tham CK; Tan MH; Lim ST
Leuk Lymphoma; 2008 Mar; 49(3):462-9. PubMed ID: 18297522
[TBL] [Abstract][Full Text] [Related]
2. Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma.
Dendle C; Gilbertson M; Spelman T; Stuart RL; Korman TM; Thursky K; Opat S; McQuilten Z
Sci Rep; 2017 Jun; 7(1):4395. PubMed ID: 28667319
[TBL] [Abstract][Full Text] [Related]
3. Does gender matter in non-hodgkin lymphoma? Differences in epidemiology, clinical behavior, and therapy.
Horesh N; Horowitz NA
Rambam Maimonides Med J; 2014 Oct; 5(4):e0038. PubMed ID: 25386354
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco-Hematológicas retrospective study.
Carella AM; de Souza CA; Luminari S; Marcheselli L; Chiappella A; di Rocco A; Cesaretti M; Rossi A; Rigacci L; Gaidano G; Merli F; Spina M; Stelitano C; Hohaus S; Barbui A; Puccini B; Miranda EC; Guida A; Federico M
Leuk Lymphoma; 2013 Jan; 54(1):53-7. PubMed ID: 22712840
[TBL] [Abstract][Full Text] [Related]
5. Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy.
Riihijärvi S; Taskinen M; Jerkeman M; Leppä S
Eur J Haematol; 2011 Feb; 86(2):124-8. PubMed ID: 20942853
[TBL] [Abstract][Full Text] [Related]
6. Semimethylation is a feature of diffuse large B-cell lymphoma, and subgroups with poor prognosis are characterized by global hypomethylation and short telomere length.
Carlund O; Thörn E; Osterman P; Fors M; Dernstedt A; Forsell MNE; Erlanson M; Landfors M; Degerman S; Hultdin M
Clin Epigenetics; 2024 May; 16(1):68. PubMed ID: 38773655
[TBL] [Abstract][Full Text] [Related]
7. Evolving therapeutic landscape of diffuse large B-cell lymphoma: challenges and aspirations.
Chan JY; Somasundaram N; Grigoropoulos N; Lim F; Poon ML; Jeyasekharan A; Yeoh KW; Tan D; Lenz G; Ong CK; Lim ST
Discov Oncol; 2023 Jul; 14(1):132. PubMed ID: 37466782
[TBL] [Abstract][Full Text] [Related]
8. [Sex-specific differences of special tumor diseases].
Lehnen N; Hallek M
Inn Med (Heidelb); 2023 Aug; 64(8):717-726. PubMed ID: 37458764
[TBL] [Abstract][Full Text] [Related]
9. Association between serum albumin levels and survival in elderly patients with diffuse large B-cell lymphoma: a single-center retrospective study.
Hu X; Feng X; Wang H; Miao Y; Lian X; Gao Q; Gao Y; Zhai X; Zhang D; Niu B; Wang Y
Transl Cancer Res; 2023 Jun; 12(6):1577-1587. PubMed ID: 37434675
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of prelymphodepletion absolute lymphocyte counts in relapsed/refractory diffuse large B-cell lymphoma patients treated with chimeric antigen receptor T cells.
Lu Y; Zhu H; Liu Y; Wang Y; Sun Y; Cheng H; Yan Z; Cao J; Sang W; Zhu F; Li D; Sun H; Zheng J; Xu K; Li Z
Front Immunol; 2023; 14():1155216. PubMed ID: 37205117
[TBL] [Abstract][Full Text] [Related]
11. An overview of the correlation between IPI and prognosis in primary breast lymphoma.
Feng K; Zhao S; Shang Q; Liu J; Yang C; Ren F; Wang X; Wang X
Am J Cancer Res; 2023; 13(1):245-260. PubMed ID: 36777506
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell Lymphoma.
Jaswal S; Sanders V; Pullarkat P; Teja S; Salter A; Watkins MP; Atagu N; Ludwig DR; Mhlanga J; Mellnick VM; Peterson LR; Bartlett NL; Kahl BS; Fehniger TA; Ghobadi A; Cashen AF; Mehta-Shah N; Ippolito JE
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740596
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNAs (lncRNAs) in human lymphomas.
Gholami A; Farhadi K; Sayyadipour F; Soleimani M; Saba F
Genes Dis; 2022 Jul; 9(4):900-914. PubMed ID: 35685474
[TBL] [Abstract][Full Text] [Related]
14. Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989-2018.
Durmaz M; Visser O; Posthuma EFM; Brouwer RE; Issa DE; de Jong D; Lam KH; Blijlevens NMA; Zijlstra JM; Chamuleau MED; Lugtenburg PJ; Kersten MJ; Dinmohamed AG
Blood Cancer J; 2022 Mar; 12(3):38. PubMed ID: 35264598
[TBL] [Abstract][Full Text] [Related]
15. Impact of C-reactive protein and albumin levels on short, medium, and long term mortality in patients with diffuse large B-cell lymphoma.
Gradel KO; Larsen TS; Frederiksen H; Vinholt PJ; Iachina M; Póvoa P; Zampieri FG; Nielsen SL; Dessau RB; Møller JK; Jensen TG; Chen M; Coia JE; Jelicic J
Ann Med; 2022 Dec; 54(1):713-722. PubMed ID: 35238275
[No Abstract] [Full Text] [Related]
16. Prognostic Role of Serum Albumin Level in Patients with Lymphoma Undergoing Autologous Stem Cell Transplantation.
Luo C; Li Q; Li X; Wu G; Huang X; Zhang Y; Ma Y; Xie M; Sun Y; Huang Y; Huang Z; Xu S; Chen J
Ann Transplant; 2021 Oct; 26():e933365. PubMed ID: 34635633
[TBL] [Abstract][Full Text] [Related]
17. Low Geriatric Nutritional Risk Index Is Associated with Poorer Prognosis in Elderly Diffuse Large B-Cell Lymphoma Patients Unfit for Intensive Anthracycline-Containing Therapy: A Real-World Study.
Chuang TM; Liu YC; Hsiao HH; Wang HC; Du JS; Yeh TJ; Gau YC; Ke YL; Yang CI; Lee CP; Hsu CM; Cho SF
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579119
[TBL] [Abstract][Full Text] [Related]
18. Primary Diffuse Large B-Cell Lymphoma of the Urinary Tract: A Population-Based Analysis.
Liu ZH; Yang LC; Song P; Fang K; Zhou J; Peng ZF; Dong Q
Front Oncol; 2021; 11():609882. PubMed ID: 34336635
[TBL] [Abstract][Full Text] [Related]
19. Trends in Incidence and Mortality of Waldenström Macroglobulinemia: A Population-Based Study.
Yin X; Chen L; Fan F; Yan H; Zhang Y; Huang Z; Sun C; Hu Y
Front Oncol; 2020; 10():1712. PubMed ID: 33014849
[No Abstract] [Full Text] [Related]
20. A genetic predictive model for precision treatment of diffuse large B-cell lymphoma with early progression.
Ma J; Yan Z; Zhang J; Zhou W; Yao Z; Wang H; Chu J; Yao S; Zhao S; Zhang P; Xu Y; Xia Q; Ma J; Wei B; Yang S; Liu K; Guo Y; Liu Y
Biomark Res; 2020; 8():33. PubMed ID: 32864130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
